Microbiome Dysbiosis
8
5
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (8)
The Bloom Infant Probiotic (BIP) Study
Pulmonary Microbiota Changes and Clinical Outcomes in Neurosurgical ICU Patients With Artificial Airways
Colon-delivered Riboflavin and Gut Microbiota Composition
Synbiotics in Patients at RIsk fOr Preterm Birth
Multi-Omics Integrative Analysis of Serum and Sputum to Uncover Key Determinants of Prognosis in Patients With ARDS
Accelerating Recovery After ICU Admission: Post-discharge Supplementation With Pasteurized Akkermansia Muciniphila.
Dynamics of Dysbiosis in the Skin and Gut Microbiome of Burn Patients
Feasibility Study of Using Fecal Microbiota Transplants in Anorexia Nervosa